Biolinq: Funding, Investors & Team (Oct 2026)
Biolinq is a company that specializes in developing digital health platforms with the goal of creating a series of biomonitoring solutions. One of their key products is a minimally invasive biosensor that is applied to the skin and analyzes biomarkers in the interstitial fluid. This biosensor provides real-time health information by continuously monitoring multiple biomarkers, making it particularly useful for diabetic patients to track their blood glucose levels.
Biolinq has raised $148M across 2 funding rounds on record, the most recent an undisclosed round of $90.0M announced in Mar 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Biolinq Company Profile and Key Stats
Latest funding round on record: Mar 2025.
Biolinq Funding Rounds
Biolinq raised $58.0M in an undisclosed round announced in Apr 2024.
11 months later, an undisclosed round of $90.0M was announced in Mar 2025.
Biolinq Founders and Leadership Team
No contact details are on record for this team yet.
Biolinq Funding Compared to Other Biotechnology Startups
Biolinq's latest round of $90.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Biolinq in Biotechnology and San Diego
Companies Similar to Biolinq
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Biolinq Funding FAQs
What does Biolinq do?
Biolinq is a company that specializes in developing digital health platforms with the goal of creating a series of biomonitoring solutions. One of their key products is a minimally invasive biosensor that is applied to the skin and analyzes biomarkers in the interstitial fluid. This biosensor provides real-time health information by continuously monitoring multiple biomarkers, making it particularly useful for diabetic patients to track their blood glucose levels.
How much funding has Biolinq raised?
Biolinq has raised $148M across 2 rounds on record. The most recent is an undisclosed round of $90.0M announced in Mar 2025.
When did Biolinq last raise funding?
Biolinq's most recent funding round on record is an undisclosed round of $90.0M, announced in Mar 2025.
Who founded Biolinq?
FundedIQ lists Joshua Windmiller (Founder) at Biolinq.
Where is Biolinq headquartered?
Biolinq is based in San Diego, California, United States.
How many employees does Biolinq have?
Biolinq is in the 51-100 employee band.
How does Biolinq's funding compare to other Biotechnology startups?
Biolinq's latest round of $90.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Biolinq Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Biolinq is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.